Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia.
about
Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Tetrathiomolybdate Treatment L ...... LPS-Stimulated BV-2 Microglia.
@en
Tetrathiomolybdate Treatment L ...... LPS-Stimulated BV-2 Microglia.
@nl
type
label
Tetrathiomolybdate Treatment L ...... LPS-Stimulated BV-2 Microglia.
@en
Tetrathiomolybdate Treatment L ...... LPS-Stimulated BV-2 Microglia.
@nl
prefLabel
Tetrathiomolybdate Treatment L ...... LPS-Stimulated BV-2 Microglia.
@en
Tetrathiomolybdate Treatment L ...... LPS-Stimulated BV-2 Microglia.
@nl
P2093
P2860
P356
P1476
Tetrathiomolybdate Treatment L ...... LPS-Stimulated BV-2 Microglia.
@en
P2093
Chuang Guo
Hui-Ling Gao
Man-Li Zhong
Rui-Fang Guo
Ting-Ting Huang
Ya-Hong Zhang
P2860
P356
10.3389/FNAGI.2018.00009
P577
2018-02-27T00:00:00Z